Breast cancer study comparing younger and older patients
Treatments studied
Part of Cancer, Skin clinical trials.
This trial looks at differences between younger and older breast cancer patients to better understand the disease. If you had breast cancer between the ages of 18 and 75 and were treated in a Chinese hospital from 2000 to 2024, you might be able to help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were first diagnosed and treated for breast cancer between January 2000 and December 2024.
- You were between 18 and 75 years old at the time of diagnosis.
- You were treated at one of the several hospitals in China taking part in this study.
- You do not have another type of cancer.
- You do not have a chronic infectious disease like HIV or severe organ problems (such as heart, liver, or kidney failure).
- You are not currently in any other condition that would make the study unsafe, as judged by the study doctor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how age-related changes in your blood might affect how well your breast cancer treatment works. It includes people with hormone receptor-positive, HER2-negative breast cancer that has not spread to distant organs.
This study looks at how “early aging” changes show up during treatment in young adults with cancer. It may help doctors better understand health effects during curative therapy and improve care for people your age.
This study looks at two specific types of breast cancer in women diagnosed either before age 45 or after age 55. Researchers want to understand how a woman's hormonal cycle may affect how aggressive the cancer is and to find better ways to treat it.
This study looks at the potential harms and benefits of hormone (endocrine) therapy in people age 70 and older with early-stage, hormone-receptor–positive breast cancer. It may help doctors choose which hormone treatment approach is safest and most helpful for older patients.
This study looks back at the medical records of people in China diagnosed with early-stage lung cancer (Stage I–III) to learn more about the disease and how it is treated. It does not involve any new treatments or tests—just reviewing information that was already collected during your care.
This study looks at young people (40 or younger at diagnosis) with solid tumors in China. It aims to collect real-world information about their treatments and outcomes to find patterns that could help improve care.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.